Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 162.32
+25.92 (19.00%)
Jun 9, 2025, 2:45 PM CST
Beijing Hotgen Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Operating Revenue | 488.01 | 510.89 | 537.9 | 3,532 | 5,307 | 511.67 | Upgrade
|
| Other Revenue | - | - | 3.35 | 24.41 | 62.65 | 1.86 | Upgrade
|
| Revenue | 488.01 | 510.89 | 541.25 | 3,557 | 5,369 | 513.53 | Upgrade
|
| Revenue Growth (YoY) | 7.39% | -5.61% | -84.78% | -33.76% | 945.54% | 144.06% | Upgrade
|
| Cost of Revenue | 1.6 | - | 209.84 | 1,766 | 2,254 | 189.95 | Upgrade
|
| Gross Profit | 486.41 | 510.89 | 331.41 | 1,790 | 3,116 | 323.59 | Upgrade
|
| Selling, General & Admin | 6.97 | - | 262.89 | 483.58 | 404.26 | 161.44 | Upgrade
|
| Research & Development | -2.24 | - | 131.45 | 191.14 | 131.92 | 47.61 | Upgrade
|
| Other Operating Expenses | 681.86 | 682.83 | 3.56 | 9.2 | 5.04 | 0.88 | Upgrade
|
| Operating Expenses | 686.59 | 682.83 | 384.74 | 695.26 | 541.92 | 211.13 | Upgrade
|
| Operating Income | -200.18 | -171.94 | -53.33 | 1,095 | 2,574 | 112.46 | Upgrade
|
| Interest Expense | - | - | -1.01 | -2.32 | -1.27 | -0.45 | Upgrade
|
| Interest & Investment Income | 33.2 | - | 39.59 | 34.52 | 34.26 | 8.42 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 4.31 | 4.95 | -14.64 | 1.7 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.65 | -4.07 | -1.17 | 3.31 | -4.82 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -170.63 | -176.01 | -11.61 | 1,135 | 2,587 | 122.12 | Upgrade
|
| Gain (Loss) on Sale of Investments | -32.74 | - | -22.31 | 7.52 | 3.12 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.75 | - | -0.64 | -0.34 | -14.21 | -0.18 | Upgrade
|
| Asset Writedown | -0.03 | - | -36.95 | -70.06 | -8.51 | -0.14 | Upgrade
|
| Other Unusual Items | -0.08 | - | 85.02 | 2.63 | 14.22 | 5.62 | Upgrade
|
| Pretax Income | -205.22 | -176.01 | 13.5 | 1,075 | 2,582 | 127.42 | Upgrade
|
| Income Tax Expense | 2.1 | 3.22 | -1.55 | 150.1 | 379.44 | 16.13 | Upgrade
|
| Earnings From Continuing Operations | -207.33 | -179.23 | 15.05 | 925.12 | 2,202 | 111.3 | Upgrade
|
| Minority Interest in Earnings | -0.97 | - | 12.33 | 19.62 | -16.61 | 0.77 | Upgrade
|
| Net Income | -208.29 | -179.23 | 27.38 | 944.74 | 2,186 | 112.07 | Upgrade
|
| Net Income to Common | -208.29 | -179.23 | 27.38 | 944.74 | 2,186 | 112.07 | Upgrade
|
| Net Income Growth | - | - | -97.10% | -56.78% | 1850.41% | 230.80% | Upgrade
|
| Shares Outstanding (Basic) | 94 | 92 | 88 | 91 | 92 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 92 | 88 | 92 | 92 | 92 | Upgrade
|
| Shares Change (YoY) | 8.41% | 4.59% | -3.88% | -0.14% | -0.12% | 23.13% | Upgrade
|
| EPS (Basic) | -2.21 | -1.94 | 0.31 | 10.33 | 23.75 | 1.22 | Upgrade
|
| EPS (Diluted) | -2.21 | -1.94 | 0.31 | 10.28 | 23.75 | 1.22 | Upgrade
|
| EPS Growth | - | - | -96.98% | -56.72% | 1852.80% | 168.66% | Upgrade
|
| Free Cash Flow | - | - | -465.31 | 413.54 | 2,246 | -7.65 | Upgrade
|
| Free Cash Flow Per Share | - | - | -5.27 | 4.50 | 24.40 | -0.08 | Upgrade
|
| Dividend Per Share | - | - | 0.200 | - | 3.378 | 1.014 | Upgrade
|
| Dividend Growth | - | - | - | - | 233.34% | 400.00% | Upgrade
|
| Gross Margin | 99.67% | 100.00% | 61.23% | 50.34% | 58.03% | 63.01% | Upgrade
|
| Operating Margin | -41.02% | -33.66% | -9.85% | 30.79% | 47.93% | 21.90% | Upgrade
|
| Profit Margin | -42.68% | -35.08% | 5.06% | 26.56% | 40.71% | 21.82% | Upgrade
|
| Free Cash Flow Margin | - | - | -85.97% | 11.63% | 41.82% | -1.49% | Upgrade
|
| EBITDA | - | -111.87 | 6.74 | 1,184 | 2,631 | 141.61 | Upgrade
|
| EBITDA Margin | - | -21.90% | 1.24% | 33.30% | 49.00% | 27.57% | Upgrade
|
| D&A For EBITDA | - | 60.07 | 60.07 | 89.39 | 57.5 | 29.15 | Upgrade
|
| EBIT | -200.18 | -171.94 | -53.33 | 1,095 | 2,574 | 112.46 | Upgrade
|
| EBIT Margin | -41.02% | -33.66% | -9.85% | 30.79% | 47.93% | 21.90% | Upgrade
|
| Effective Tax Rate | - | - | - | 13.96% | 14.70% | 12.66% | Upgrade
|
| Revenue as Reported | - | - | 541.25 | 3,557 | 5,369 | 513.53 | Upgrade
|
| Advertising Expenses | - | - | 13.08 | 55.08 | 68.41 | 7.17 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.